FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC)

CUSIP: 31447P100

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
-536,543
Put/Call ratio
0.23%
SEC-reported price per share
$11.12
Number of holders
64
Value change
-$6,099,282
Number of buys
35
Open additional details 1 more signal available
Number of sells
22
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
35,203,113

Security key

31447P100

Report period

Q1 2024

Institutions

64

Top holders

10

Ownership snapshot

Top reported holders of FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Southpoint Capital Adviso...
Disclosed value leader
Southpoint Capital Adviso...
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F Highest disclosed value: $45,746,341 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Southpoint Capital Advisors LP has the largest disclosed position value at $45.75M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Southpoint Capital Advisors LP's linked filing trail.
Disclosed position value Top 5
Southpoint Capital Advisors LP $45.75M
Sonic GP LLC $27.01M
Solas Capital Management, LLC $15.47M
Avoro Capital Advisors LLC $13.46M
VANGUARD GROUP INC $12.79M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Southpoint Capital Advisors LP
13F
Company
13F
—
denominator unverified
$45,746,341
4,077,214 shares
— 31 Dec 2023
Sonic GP LLC
13F
Company
13F
—
denominator unverified
$27,010,546
2,407,357 shares
— 31 Dec 2023
Solas Capital Management, LLC
13F
Company
13F
—
denominator unverified
$15,466,916
1,378,513 shares
— 31 Dec 2023
Avoro Capital Advisors LLC
13F
Company
13F
—
denominator unverified
$13,464,000
1,200,000 shares
— 31 Dec 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$12,791,507
1,140,063 shares
— 31 Dec 2023
DG Capital Management, LLC
13F
Company
13F
—
denominator unverified
$12,068,613
1,075,634 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
64
Shares
14,487,904
Rows available
64
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q4 2025 Across Filers

Q4 2025 holders
96
Q1 2024 holders
64
Holder diff
-32
Investor Q4 2025 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2025 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .